HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuo Shoji Selected Research

IDL Lipoproteins (Lipoprotein, IDL)

12/2009Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
9/2004Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome.
1/2002Effect of diabetes on uremic dyslipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuo Shoji Research Topics

Disease

38Type 2 Diabetes Mellitus (MODY)
05/2021 - 03/2002
27Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2002
26Chronic Kidney Failure (Chronic Renal Failure)
02/2022 - 09/2001
24Atherosclerosis
12/2019 - 01/2002
23Insulin Resistance
12/2019 - 06/2002
15Diabetes Mellitus
12/2022 - 06/2002
15Chronic Renal Insufficiency
10/2021 - 05/2003
11Renal Insufficiency (Renal Failure)
10/2021 - 06/2002
10Inflammation (Inflammations)
05/2021 - 11/2003
10Vascular Calcification
09/2020 - 09/2004
9Dyslipidemias (Dyslipidemia)
10/2021 - 08/2006
7Hypertension (High Blood Pressure)
07/2022 - 09/2004
7Obesity
09/2018 - 06/2002
6Proteinuria
07/2022 - 07/2006
6Carotid Artery Diseases
01/2013 - 01/2005
6Uremia
10/2012 - 03/2004
5Infections
11/2022 - 09/2004
5Stroke (Strokes)
01/2022 - 08/2015
4Diabetic Nephropathies (Diabetic Nephropathy)
12/2021 - 01/2003
4Secondary Hyperparathyroidism
01/2021 - 12/2003
4Myocardial Infarction
12/2018 - 08/2006
4Peripheral Arterial Disease
01/2016 - 01/2005
4Coronary Artery Disease (Coronary Atherosclerosis)
08/2010 - 01/2003
3Nephrotic Syndrome (Syndrome, Nephrotic)
02/2022 - 05/2015
3Fatigue
10/2021 - 04/2010
3Anemia
01/2021 - 05/2003
3Ischemia
12/2018 - 08/2010
3Arteriosclerosis
07/2016 - 05/2005
3Hyperglycemia
03/2015 - 01/2002
3Malnutrition (Nutritional Deficiencies)
04/2012 - 09/2004
3Hypercholesterolemia
02/2010 - 01/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2008 - 12/2005
3Hyperphosphatemia
01/2008 - 05/2004
2Albuminuria
07/2022 - 12/2020
2Euthyroid Sick Syndromes (Euthyroid Sick Syndrome)
12/2021 - 10/2021
2Hypothyroidism
10/2021 - 01/2021
2Abdominal Obesity
10/2020 - 02/2011
2Sarcopenia
01/2019 - 01/2019
2Heart Failure
12/2018 - 03/2011
2Cerebral Infarction
01/2017 - 05/2011
2Hypoglycemia (Reactive Hypoglycemia)
01/2016 - 11/2015
2Hyperlipidemias (Hyperlipidemia)
06/2015 - 05/2015

Drug/Important Bio-Agent (IBA)

12Insulin (Novolin)FDA Link
07/2022 - 07/2002
11AdiponectinIBA
12/2019 - 01/2003
11Glucose (Dextrose)FDA LinkGeneric
11/2015 - 07/2002
10LipidsIBA
07/2016 - 03/2002
9oxidized low density lipoproteinIBA
02/2022 - 12/2002
9C-Reactive ProteinIBA
03/2021 - 12/2002
9Vitamin DFDA LinkGeneric
12/2018 - 12/2003
9HDL CholesterolIBA
10/2017 - 06/2002
8alpha-2-HS-GlycoproteinIBA
01/2021 - 02/2006
8CholesterolIBA
03/2015 - 05/2003
7Biomarkers (Surrogate Marker)IBA
08/2022 - 03/2009
7CreatinineIBA
12/2021 - 05/2003
6Serum AlbuminIBA
12/2021 - 05/2003
6AlbuminsIBA
12/2021 - 09/2005
6Triglycerides (Triacylglycerol)IBA
10/2017 - 01/2002
5Proteins (Proteins, Gene)FDA Link
11/2022 - 05/2011
5Calcitriol Receptors (Calcitriol Receptor)IBA
01/2021 - 06/2011
5LeptinIBA
09/2018 - 03/2005
5Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2018 - 09/2013
5Lipoproteins (Lipoprotein)IBA
01/2015 - 01/2002
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2022 - 01/2005
4Pharmaceutical PreparationsIBA
02/2022 - 01/2005
4Indicators and Reagents (Reagents)IBA
10/2020 - 05/2003
4Pioglitazone (Actos)FDA Link
06/2014 - 06/2005
4LDL CholesterolIBA
04/2014 - 01/2007
4MineralsIBA
06/2013 - 09/2005
4HDL LipoproteinsIBA
12/2009 - 06/2002
3LDL Lipoproteins (beta Lipoproteins)IBA
02/2022 - 12/2009
3Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2021 - 01/2021
3Arachidonic Acid (Vitamin F)IBA
01/2018 - 09/2013
3Docosahexaenoic AcidsIBA
01/2018 - 09/2013
3Eicosapentaenoic AcidIBA
01/2018 - 09/2013
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2016 - 06/2005
3Advanced Glycation End ProductsIBA
04/2011 - 12/2005
3IDL Lipoproteins (Lipoprotein, IDL)IBA
12/2009 - 01/2002
3Parathyroid Hormone (Parathormone)IBA
09/2004 - 06/2002
2RNA (Ribonucleic Acid)IBA
07/2022 - 04/2022
2Thyroxine (Levothyroxine)FDA LinkGeneric
12/2021 - 01/2021
2Triiodothyronine (Liothyronine)FDA LinkGeneric
12/2021 - 10/2021
2ZincIBA
05/2021 - 09/2020
2maxacalcitolIBA
01/2021 - 12/2003
2Hemoglobins (Hemoglobin)IBA
10/2020 - 05/2003
2CytokinesIBA
02/2020 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
02/2020 - 01/2019
2Oncostatin MIBA
02/2020 - 01/2019
2alfacalcidolIBA
12/2018 - 01/2004
2Hormones (Hormone)IBA
09/2018 - 01/2014
2Glycoproteins (Glycoprotein)IBA
03/2018 - 08/2010
2Leptin ReceptorsIBA
01/2018 - 01/2013
2AndrogensIBA
03/2015 - 10/2012
2glimepiride (Amarel)FDA LinkGeneric
06/2014 - 02/2009

Therapy/Procedure

52Renal Dialysis (Hemodialysis)
11/2022 - 09/2001
10Therapeutics
05/2015 - 03/2003
7Glycemic Control
10/2020 - 03/2005
4Blood Component Removal (Apheresis)
02/2022 - 08/2006
2Surgical Amputation (Amputations)
12/2018 - 01/2016
2Injections
03/2018 - 11/2014
2Aftercare (After-Treatment)
06/2015 - 08/2006